---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-001563"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2023-01-04T23:59:59+00:00"
generated_at: "2026-06-20T20:08:30.784873+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Nasdaq notified Alaunos on Jan 4, 2023 that TCRT bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 days (until July 3, 2023) to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by July 3, may seek 180-day extension by transferring to Nasdaq Capital Market.
- No assurance of regaining compliance; delisting remains a risk.

## SEC filing metadata
- accession: 0001193125-23-001563
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2023-01-04T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000119312523001563/0001193125-23-001563-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000119312523001563/d446553d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-001563
- JSON: https://secwatch.observer/filing/0001193125-23-001563.json
- Plain text: https://secwatch.observer/filing/0001193125-23-001563.txt

## Key facts
- Listing & Compliance Notices
  Alaunos Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: January 4, 2023, Alaunos Therapeutics, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock, par value $0.001 per share (the “Common Stock”), had closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(
  evidence_url: https://www.sec.gov/Archives/edgar/data/1107421/000119312523001563/0001193125-23-001563-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.